MiMedx Ranked in Top 100 Georgia Public Companies

MiMedx Group, Inc. (NASDAQ: MDXG) has been selected to the 2013 Top 100 Georgia Public Companies. This prestigious list is sponsored by GeorgiaTrend Magazine and determined by S&P Capital IQ. The 2013 list is based on fiscal year 2012 financial results.

The 2013 publication marks the first year that MiMedx has reached Georgia's Top 100 Public Companies list. MiMedx is one of two Georgia-based public healthcare companies to join the Top 100 in 2013.

Mr. Pete Petit said, "We are pleased with our inaugural inclusion in the 2013 Top 100 Public Companies in Georgia. We are flattered that the GeorgiaTrend article unveiling the 2013 list recognized MiMedx for our recent accomplishments, including adding over 100 new jobs in the Atlanta area, developing our new headquarters facility, doubling our manufacturing capacity and tripling our 2012 sales over 2011. As more results from our clinical studies chronicling the clinical and cost effectiveness of our PURION® processed dehydrated human amnion/chorion membrane allografts are published, we expect the demand for our tissue allografts to continue to increase."